Health In Tech, Inc. Files S-1 for Public Offering

TL;DR

Health In Tech, Inc. just filed its S-1, signaling a move towards an IPO. Get ready for potential market shifts.

AI Summary

Health In Tech, Inc. filed an S-1 registration statement with the SEC on August 30, 2024, under the Securities Act of 1933. The company, incorporated in Nevada, operates in the insurance agents, brokers & services sector. Its principal executive offices are located at 701 S. Colorado Ave, Suite 1, Stuart, FL 34994, with a contact phone number of 888-373-0333.

Why It Matters

This S-1 filing marks Health In Tech, Inc.'s initial step towards becoming a publicly traded company, potentially impacting the insurance technology sector.

Risk Assessment

Risk Level: medium — As an S-1 filing, it represents an early stage of a company's public offering, with inherent uncertainties and risks associated with new public companies.

Key Numbers

• 333-281853 — SEC File Number (Identifies this specific SEC filing.)
• 0002019505 — Central Index Key (Unique identifier for the company in SEC filings.)

Key Players & Entities

• Health In Tech, Inc. (company) — Registrant
• August 30, 2024 (date) — Filing Date
• Securities Act of 1933 (legal_document) — Governing Act
• Nevada (jurisdiction) — State of Incorporation
• 6411 (industry_code) — Standard Industrial Classification
• 701 S. Colorado Ave, Suite 1 Stuart, FL 34994 (address) — Principal Executive Offices
• 888-373-0333 (phone_number) — Business Phone
• Tim Johnson (person) — Chief Executive Officer

FAQ

Key Financial Figures

• $0.001 — shares of Class A Common Stock, $0.001 par value per share (“Class&#x00
• $4.00 — price anticipated to be in the range of $4.00 to $5.00 per share, through the underwr
• $5.00 — icipated to be in the range of $4.00 to $5.00 per share, through the underwriter name
• $4.5 — ission To change the non -transparent $4.5 trillion 1 healthcare industry w

Filing Documents

• ea0200040-08.htm (S-1) — 9050KB
• ea020004008ex3-1_health.htm (EX-3.1) — 98KB
• ea020004008ex3-2_health.htm (EX-3.2) — 85KB
• ea020004008ex4-1_health.htm (EX-4.1) — 2KB
• ea020004008ex10-1_health.htm (EX-10.1) — 82KB
• ea020004008ex10-2_health.htm (EX-10.2) — 81KB
• ea020004008ex10-3_health.htm (EX-10.3) — 82KB
• ea020004008ex10-4_health.htm (EX-10.4) — 81KB
• ea020004008ex10-5_health.htm (EX-10.5) — 83KB
• ea020004008ex10-6_health.htm (EX-10.6) — 80KB
• ea020004008ex10-7_health.htm (EX-10.7) — 476KB
• ea020004008ex10-8_health.htm (EX-10.8) — 52KB
• ea020004008ex10-9_health.htm (EX-10.9) — 144KB
• ea020004008ex10-10_health.htm (EX-10.10) — 31KB
• ea020004008ex10-11_health.htm (EX-10.11) — 110KB
• ea020004008ex21-1_health.htm (EX-21.1) — 1KB
• ea020004008ex23-2_health.htm (EX-23.2) — 3KB
• ea020004008ex99-1_health.htm (EX-99.1) — 2KB
• ea020004008ex99-2_health.htm (EX-99.2) — 2KB
• ea020004008ex99-3_health.htm (EX-99.3) — 2KB
• ea020004008ex99-4_health.htm (EX-99.4) — 5KB
• ea020004008ex-fee_health.htm (EX-FILING FEES) — 13KB
• thealth_logo.jpg (GRAPHIC) — 148KB
• tamerican_logo.jpg (GRAPHIC) — 71KB
• timage_01.jpg (GRAPHIC) — 351KB
• timage_02.jpg (GRAPHIC) — 489KB
• timage_09.jpg (GRAPHIC) — 818KB
• timage_04.jpg (GRAPHIC) — 661KB
• timage_05.jpg (GRAPHIC) — 483KB
• timage_06.jpg (GRAPHIC) — 642KB
• timage_07.jpg (GRAPHIC) — 572KB
• timage_08.jpg (GRAPHIC) — 809KB
• thealth_logo1.jpg (GRAPHIC) — 147KB
• ex4-1_001.jpg (GRAPHIC) — 570KB
• ex4-1_002.jpg (GRAPHIC) — 266KB
• ex10-6_001.jpg (GRAPHIC) — 19KB
• ex10-7_001.jpg (GRAPHIC) — 2KB
• 0001213900-24-074106.txt ( ) — 18899KB

RISK FACTORS

RISK FACTORS   15 CAUTIONARY NOTE REGARDING FORWARD-LOOKING STATEMENTS   36

USE OF PROCEEDS

USE OF PROCEEDS   37 DIVIDEND POLICY   38 CAPITALIZATION   39

DILUTION

DILUTION   41 MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS   43

BUSINESS

BUSINESS   67 MANAGEMENT   79 EXECUTIVE AND DIRECTOR COMPENSATION   85 PRINCIPAL STOCKHOLDERS   92 CERTAIN RELATIONSHIPS AND RELATED PARTY TRANSACTIONS   94

DESCRIPTION OF CAPITAL STOCK

DESCRIPTION OF CAPITAL STOCK   95 SHARES ELIGIBLE FOR FUTURE SALE   100

UNDERWRITING

UNDERWRITING   102 EXPERTS   113 LEGAL MATTERS   113 WHERE YOU CAN FIND MORE INFORMATION   113 INDEX TO CONSOLIDATED FINANCIAL STATEMENTS   F-1 You should rely only on the information contained in this prospectus. We have not authorized any other person to provide you with information different from or in addition to that contained in this prospectus, and we take no responsibility for any other information others may give you. If anyone provides you with different or inconsistent information, you should not rely on it. We are not making an offer to sell these securities in any jurisdiction where an offer or sale is not permitted. You should assume that the information appearing in this prospectus is accurate only as of the date on the front cover of this prospectus. Our business, financial condition, results of operations and prospects may have changed since that date. No action is being taken in any jurisdiction outside the United States to permit a public offering of our Class A Common Stock or possession or distribution of this prospectus in that jurisdiction. Persons who come into possession of this prospectus in jurisdictions outside the United States are required to inform themselves about and to observe any restrictions as to this offering and the distribution of this prospectus applicable to that jurisdiction. As used in this prospectus, unless the context indicates or otherwise requires, “the Company,” “our Company,” “we,” “us,” and “our” refer to Health In Tech, Inc., a Nevada corporation, and its consolidated subsidiaries. i Table of Contents CERTAIN TERMS AND DEFINITIONS •          “Broker” or “insurance broker” is an intermediary who sells, solicits or negotiates insurance policies on behalf of a client for

View Full Filing

View this S-1 filing on SEC EDGAR